(Q35206943)

7 August 2017

1 reference

title

New metal complexes as potential therapeutics (English)

1 reference

7 August 2017

Christiana Xin Zhang

1

1 reference

PubMed ID

12941423

7 August 2017

Stephen J Lippard

series ordinal

2

1 reference

7 August 2017

1 August 2003

1 reference

Current Opinion in Chemical Biology

7 August 2017

1 reference

7 August 2017

7

1 reference

7 August 2017

481-489

1 reference

7 August 2017

4

1 reference

Medicinal inorganic chemistry: introduction

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Metal complexes as photo- and radiosensitizers

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Metal complexes as enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Therapeutic radiopharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Treatment of Wilson and menkes diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Design and therapeutic application of matrix metalloproteinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Metal complexing agents as therapies for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Structure, Recognition, and Processing of Cisplatin-DNA Adducts.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Cisplatin: from DNA damage to cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Recognition of cisplatin adducts by cellular proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Testis-specific HMG-domain protein alters the responses of cells to cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Binding to cisplatin-modified DNA by the Saccharomyces cerevisiae HMGB protein Nhp6A.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Nucleotide excision repair from site-specifically platinum-modified nucleosomes.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Cisplatin-loaded polymer-metal complex micelle with time-modulated decaying property as a novel drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Design of macromolecular prodrug of cisplatin using dextran with branched galactose units as targeting moieties to hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Cholic acid-carboplatin compounds (CarboChAPt) as models for specific drug delivery: synthesis of novel carboplatin analogous derivatives and comparison of the cytotoxic properties with corresponding cisplatin compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Hematoporphyrin-derived soluble porphyrin-platinum conjugates with combined cytotoxic and phototoxic antitumor activity

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Current status of trans-platinum compounds in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

p53-Dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair of DNA intrastrand cross-links of novel antitumor trinuclear platinum complex BBR3464

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

DNA interstrand cross-links of the novel antitumor trinuclear platinum complex BBR3464. Conformation, recognition by high mobility group domain proteins, and nucleotide excision repair

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Molecular aspects of resistance to antitumor platinum drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Different recognition of DNA modified by aatitumor cisplatin and its clinically ineffective trans isomer by tumor suppressor protein p53.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Mononuclear platinum(II) complex with 2-phenylpyridine ligands showing high cytotoxicity against mouse sarcoma 180 cells acquiring high cisplatin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Design, synthesis, and biological activity of a novel non-cisplatin-type platinum-acridine pharmacophore

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Cytotoxic acridinylthiourea and its platinum conjugate produce enzyme-mediated DNA strand breaks

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

High-throughput synthesis and screening of platinum drug candidates

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Transferrin/transferrin receptor-mediated drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

The anti-metastatic agent imidazolium trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces endothelial cell apoptosis by inhibiting the mitogen-activated protein kinase/extracellular signal-regulated kinase signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Topoisomerase II antagonism and anticancer activity of coordinated derivatives of [RuCl(2)(C(6)H(6))(dmso)].

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Inhibition of cancer cell growth by ruthenium(II) arene complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

In vitro and in vivo antitumor properties of tetrakis((trishydroxy- methyl)phosphine)gold(I) chloride.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Functional mimics of superoxide dismutase enzymes as therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Electrostatic contribution in the catalysis of O2*- dismutation by superoxide dismutase mimics. MnIIITE-2-PyP5+ versus MnIIIBr8T-2-PyP+.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant.

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Manganese(III) biliverdin IX dimethyl ester: a powerful catalytic scavenger of superoxide employing the Mn(III)/Mn(IV) redox couple

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Hypotensive properties and acute toxicity of trans-[Ru(NH(3))(4)P(OEt)(3)(NO)](PF(6))(3), a new nitric oxide donor

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

In vivo effects of the controlled NO donor/scavenger ruthenium cyclam complexes on blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Ruthenium(III) polyaminocarboxylate complexes: efficient and effective nitric oxide scavengers

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

Mechanistic studies on AMD6221: a ruthenium-based nitric oxide scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1367-5931%2803%2900081-4

7 January 2021

10.1016/S1367-5931(03)00081-4

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12941423